FIGURE 5
FROM:
Assessment of the aversive consequences of acute and chronic administration of the melanocortin agonist, MTII
S C Benoit, R J Sheldon, E L Air, P Messerschmidt, K A Wilmer, K M B Hodge, M B Jones, D M M Eckstein, C C McOsker, S C Woods and R J Seeley
BACK TO ARTICLEFigure 5.
Mean preference ratio during the 24-h test after Experiment 2a. * P<0.05.
